Causes of amino acid metabolism disorders: A Synthesis of Findings from 3 Studies

  1. Home
  2. Causes of amino acid metabolism disorders
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Causes of amino acid metabolism disorders: A Synthesis of Findings from 3 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Causes of amino acid metabolism disorders: A Synthesis of Findings from 3 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Major Research Findings

A randomized, single-blinded study of memory in seniors suggests that complex antioxidants may be beneficial. 2

The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) may be useful in screening for mild cognitive impairment (MCI) and Alzheimer's disease (AD). 3

Memantine use in patients with moderate to severe Alzheimer's disease is associated with substantial medical and non-medical costs. 1

Reasons for the Causes

These studies explore potential causes and treatments for Alzheimer's disease. The causes of Alzheimer's disease are complex, and oxidative stress to the brain may be involved. 2

General Causes

Oxidative Stress to the Brain

Oxidative stress to the brain is considered a potential cause of Alzheimer's disease. 2

Aging

Aging is considered one of the risk factors for Alzheimer's disease. 2

Mild Cognitive Impairment

Mild cognitive impairment (MCI) can be a precursor to Alzheimer's disease. 3

Countermeasures for Causes

Complex Antioxidants

Complex antioxidants may help reduce oxidative stress to the brain. 2

Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog)

ADAS-Cog can help detect MCI and Alzheimer's disease early. 3

Comparison Between Studies

Commonalities of Studies

All three studies focus on cognitive decline in older adults. Furthermore, these studies play a significant role in understanding and developing treatments for Alzheimer's disease.

Differences of Studies

These studies differ in terms of the subjects, research design, and outcomes. Study 1 evaluates the effectiveness of complex antioxidants. Study 2 evaluates the effectiveness of ADAS-Cog. Study 3 performs a cost analysis of memantine.

Notes on Applying to Real Life

While these research findings provide important implications for the prevention and treatment of Alzheimer's disease, it is important to exercise caution when directly applying them to clinical practice. Furthermore, these studies highlight the need for more extensive research on Alzheimer's disease.

Limitations of Current Research

These studies all have specific limitations. For example, study 1 has a small sample size, and study 2 focuses on specific types of cognitive impairment. Study 3 focuses only on the cost of memantine and does not consider patient quality of life.

Future Research Directions

More research is needed on the prevention and treatment of Alzheimer's disease. These studies should include larger sample sizes and different types of cognitive impairment. They should also consider quality of life, cost, and other relevant factors.

Conclusion

These studies provide important information about Alzheimer's disease, but more research is needed. It is also important to make lifestyle changes, such as diet, exercise, and cognitive stimulation, to prevent and treat Alzheimer's disease.

Literature analysis of 3 papers
Positive Content
3
Neutral Content
0
Negative Content
0
Article Type
2
0
1
0
3
1.

Resource utilisation and cost analysis of memantine in patients with moderate to severe Alzheimer's disease.

Author: WimoAnders, WinbladBengt, StöfflerAlbrecht, WirthYvonne, MöbiusHans-Jörg

Alzheimer's disease treatment
Cost-saving

Memantine treatment for moderate to severe Alzheimer's disease (AD) resulted in lower resource utilization and total health costs compared to placebo. Caregiver time was significantly less in the memantine group, and patients were less likely to require institutionalization. The cost savings from a societal perspective were primarily due to lower caregiver costs and direct non-medical costs.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Clinical Trial, Phase IIIA Phase III trial is a trial that further rigorously verifies the efficacy and safety of a new drug or treatment, whose efficacy and safety have been confirmed in a Phase II trial, in a large number of patients, and evaluates whether it is superior to existing treatments.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

2.

Complex antioxidants in a randomized single-blinded study of memory in seniors.

Author: SummersWilliam K, MartinRoy L, LiuYimeng, PeñaBernice, MarshGary M

Improved memory
Reduced oxidative injury

A complex antioxidant blend, sold as an over-the-counter (OTC) supplement, can improve memory in older subjects. The study involved 30 subjects who received the antioxidant blend for 6 months and showed significant improvement in declarative memory compared to a control group. Antioxidants may be beneficial in Alzheimer's disease (AD) and other neurodegenerative diseases.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

3.

Is the Alzheimer's Disease Assessment Scale-Cognitive Subscale Useful in Screening for Mild Cognitive Impairment and Alzheimer's Disease? A Systematic Review.

Author: ParkSeong-Hi, HanKuem Sun

Early screening

A review of 14 studies found that the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) has high predictive validity as a screening tool for both mild cognitive impairment (MCI) and Alzheimer's disease (AD). The ADAS-Cog demonstrated better diagnostic performance in patients with AD.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.